Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 55 | −3 |
| Shares | 5.93M | 89.7K | 6.96M | +1.12M (+19.1%) |
| Value | $15.2M | $230.5K | $17.0M | +$1.96M (+13.1%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 111,519 | $272.1K | 0.00% |
| BlackRock, Inc. | 92,009 | $224.5K | 0.00% |
| Marshall Wace, LLP | 22,527 | $55.0K | 0.00% |
| Citadel Advisors LLC | 21,402 | $52.2K | 0.00% |
| Prelude Capital Management, LLC | 14,435 | $35.2K | 0.00% |
| FMR LLC | 1,500 | $3.66K | 0.00% |
| Nordwand Advisors, LLC | 1,000 | $2.44K | 0.00% |
| Jones Financial Companies LLLP | 572 | $1.42K | 0.00% |
Sold out (11)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 38,566 | $99.1K |
| Oxford Asset Management LLP | 10,072 | $25.9K |
| JPMorgan Chase & Co | 6,921 | $17.8K |
| Rhumbline Advisers | 1,830 | $4.70K |
| Compagnie Lombard Odier SCmA | 875 | $2.25K |
| Russell Investments Group, Ltd. | 250 | $643 |
| Mather Group, LLC. | 100 | $292 |
| Qube Research & Technologies Ltd | 107 | $275 |
| Global Retirement Partners, LLC | 100 | $257 |
| Innealta Capital, LLC | 13 | $33 |
| Simplex Trading, LLC | 75 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 89,706 | $230.5K |